Ramelteon Dual Release Tablets(Triastek)
雷美替胺双释片（南京三迭纪医药）
Report date: 2025/09/23 09:54:40
Base Information
Drug NameRamelteon Dual Release Tablets(Triastek)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Triastek Pharmaceutical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNanjing Triastek Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A